|
|
Article: ICOS GETS $313.5M OFFERING THROUGH, DESPITE TIGHT MARKET.(Biotechnology firm's initial public offering)(Brief Article)
- Article from:
- BIOWORLD Today
- Article date:
- November 9, 2001
- Author:
CopyrightCOPYRIGHT 2001 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In a stiff fund-raising year - a year that has seen an 82 percent reduction in the amount of funds raised through public offerings - ICOS Corp. pulled off the largest public stock offering in 2001, pricing 5.5 million shares at $57 and raking in $313.5 million.
With underwriters having an option for another 815,789 shares to cover overallotments, the total take could be about $360 million. Credit Suisse First Boston Corp., of New York, and Merrill Lynch, Pierce, Fenner & Smith Inc., of New York, are joint lead managers. SG Cowen Securities Corp., of New York; Banc of America Securities LLC, of New York; and Robertson Stephens Inc., of San Francisco, are ...
Related newspaper, magazine, and journal articles:
|
|
Article: Cel-Sci Acquisition Inc., of the British Virgin Islands, ...
BIOWORLD Today;
August 23, 1999 ;
700+ words
... ... Corp.'s legal counsel. (See BioWorld Today, Aug. 20, 1999, p. 1 ... Bristol-Myers Squibb Co., of New York, as part of its license and ... 87 million in cash. (See BioWorld Today, Aug. 3, 1999, p. 1 ...
|
|